Latest Period
Q1 2026
Security Snapshot
Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI) Institutional Ownership
CUSIP: 81726A209
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
15
Shares (Excl. Options)
5,628,207
Price
$0.81
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SNTI on Nasdaq
- Shares outstanding
- 47,159,139
- Price per share
- $1.01
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 5,628,207
- Total reported value
- $4,570,053
- % of total 13F portfolios
- 0%
- Share change
- +13,842
- Value change
- -$8,308
- Number of holders
- 15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- SNTI - Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 81726A209.
- 15 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 15 between Q4 2025 and Q1 2026.
- Reported value moved from $5,838,757 to $4,570,053.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 15 institutions filings for Q1 2026.
Security key
81726A209
Latest holder period
Q1 2026
13F holders
15
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
SNTI full holder history
Senti Biosciences Holdings, Inc. SEC filings
Senti Biosciences Holdings, Inc. company facts
Senti Biosciences Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 81726A209:
Significant Owners of Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Celadon Partners SPV 24 | 55% | +21% | $23,174,001 | +$11,013,811 | 25,748,890 | +91% | Celadon Partners SPV 24 | 27 Apr 2026 |
| BAYER HEALTHCARE LLC | 18% | $4,729,993 | 6,142,848 | Bayer HealthCare LLC | 27 Mar 2026 | |||
| New Enterprise Associates 15, L.P. | 14% | $11,968,700 | 3,775,615 | New Enterprise Associates 15, L.P. | 06 Mar 2025 | |||
| Nantahala Capital Management, LLC | 8.1% | -19% | $7,037,400 | +$5,422,973 | 2,220,000 | +336% | Nantahala Capital Management, LLC | 31 Mar 2025 |
| ARMISTICE CAPITAL, LLC | 5% | -50% | $4,564,204 | +$2,865,052 | 1,439,812 | +169% | Armistice Capital, LLC | 31 Mar 2025 |
| Nantahala Capital Partners Limited Partnership | 1.9% | -67% | $1,592,925 | +$637,170 | 502,500 | +67% | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 31 Mar 2025 |
As of 31 Mar 2026, 15 institutional investors reported holding 5,628,207 shares of Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI). This represents 12% of the company’s total 47,159,139 outstanding shares.
Top 19 Institutional Shareholders
The largest institutional shareholders of Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 8% | 3,775,615 | 0% | 0.17% | $3,065,799 |
| Nantahala Capital Management, LLC | 1.9% | 888,000 | 0% | 0.05% | $721,056 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 537,504 | 0% | 0% | $436,453 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.44% | 207,043 | +43% | 0% | $168,122 |
| VANGUARD FIDUCIARY TRUST CO | 0.19% | 91,193 | 0% | 0% | $74,049 |
| Menlo Ventures Management, L.P. | 0.08% | 35,737 | 0% | 0.01% | $29,018 |
| BlackRock, Inc. | 0.05% | 25,074 | +7.2% | 0% | $20,360 |
| XTX Topco Ltd | 0.04% | 17,277 | 0% | $14,029 | |
| NORTHERN TRUST CORP | 0.04% | 16,778 | 0% | 0% | $13,624 |
| HRT FINANCIAL LP | 0.03% | 14,844 | 0% | $12,000 | |
| STATE STREET CORP | 0.02% | 10,010 | 0% | 0% | $8,128 |
| UBS Group AG | 0.02% | 8,637 | +91% | 0% | $7,013 |
| SBI Securities Co., Ltd. | 0% | 334 | -0.6% | 0% | $271 |
| MORGAN STANLEY | 0% | 160 | 0% | 0% | $130 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | $1 | |
| Tower Research Capital LLC (TRC) | 0% | 0 | -100% | $0 | |
| Virtu Financial LLC | 0% | 0 | -100% | $0 | |
| BANK OF AMERICA CORP /DE/ | 0% | 0 | -100% | $0 | |
| JANE STREET GROUP, LLC | 0% | 0 | -100% | $0 |
Institutional Holders of Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 5,628,207 | $4,570,053 | -$8,308 | $0.81 | 15 |
| 2025 Q4 | 5,614,365 | $5,838,757 | -$78,561 | $1.04 | 15 |
| 2025 Q3 | 5,609,415 | $7,909,282 | -$2,933,848 | $1.41 | 15 |
| 2025 Q2 | 6,484,682 | $13,682,488 | +$1,724,635 | $2.11 | 14 |
| 2025 Q1 | 5,663,433 | $19,029,155 | +$16,777,530 | $3.36 | 14 |
| 2024 Q4 | 667,184 | $2,341,958 | -$330,207 | $3.51 | 14 |
| 2024 Q3 | 763,984 | $1,726,485 | +$1,717,436 | $2.26 | 12 |